Published August 2015 | Version v1
Journal article

18F-FDG uptake at the surgical margin after hepatic resection: Patterns of uptake and differential diagnosis

  • 1. University New Mexico, Department of Radiology, Albuquerque, NM (United States)
  • 2. University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, Houston, TX (United States)
  • 3. University of Texas MD Anderson Cancer Center, Department of Biostatistics, Unit 1411, Houston, TX (United States)
  • 4. University of Texas MD Anderson Cancer Center, Department of Nuclear Medicine, Unit 1483, Houston, TX (United States)
  • 5. University of Texas MD Anderson Cancer Center, Department of Diagnostic Radiology, Unit 1473, Houston, TX (United States)
  • 6. Cairo University, National Cancer Center, Cairo (Egypt)

Description

To evaluate the patterns of 18F-FDG uptake at the surgical margin after hepatectomy to identify features that may differentiate benign and malignant uptake. Patients who had undergone a PET/CT after hepatectomy were identified. Delay between resection and PET/CT, presence of uptake at the surgical margin, pattern of uptake, and maximal standardized value were recorded. The PET/CT findings were correlated with contrast-enhanced CT or MRI. There were 26 patients with increased 18F-FDG uptake; uptake was diffuse in seven and focal in 19. Diffuse uptake was due to inflammation in all cases. Focal uptake was due to recurrence in 12 and inflammation in seven cases. Defining a focal pattern only as a positive for malignancy yielded 100 % sensitivity, 87 % specificity, 37 % false positive rate. As expected, SUVmax was significantly higher for recurrence than inflammation, but did overlap. Contrast-enhanced CT allowed differentiation between malignant and benign uptake in all cases. F-FDG uptake after hepatectomy does not equate to recurrence and yields a high false positive rate. Diffuse uptake did not require additional evaluation in our sample. Focal uptake, however, may be due to recurrence; differentiating benign and malignant nodular uptake relies on optimal contrast-enhanced CT or MRI. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-015-3631-5

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
25
Journal Issue
8
Journal Page Range
p. 2453-2459
ISSN
0938-7994
CODEN
EURAE3